(Q36368946)

13 August 2017

1 reference

title

Antihypertensive drugs: individualized analysis and clinical relevance of kinetic-dynamic relationships (English)

1 reference

13 August 2017

Antihypertensive drugs: Individualized analysis and clinical relevance of kinetic-dynamic relationships (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

20 October 2022

author name string

R. Donnelly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1641402

20 October 2022

H. L. Elliott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1641402

20 October 2022

P. A. Meredith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1641402

20 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1641402

20 October 2022

publication date

1 January 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:016372589290044Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

https://api.elsevier.com/content/article/PII:016372589290044Z?httpAccept=text/plain

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Pharmacology & Therapeutics

20 October 2022

published in

1 reference

13 August 2017

volume

53

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

67-79

1 reference

Diuretic effect and diuretic efficiency after intravenous dosage of frusemide

13 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect

20 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Individual responses to converting enzyme inhibitors and calcium antagonists

20 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system

20 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Factors in the choice of antihypertensive therapy

20 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

20 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

The place of the calcium antagonist verapamil in antihypertensive therapy

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects

20 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

EFFECTS OF ORAL DIURETICS ON RAISED ARTERIAL PRESSURE

20 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

An overview of the clinical pharmacology of enalapril

20 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Humoral and Renal Effects of MK-421 (Enalapril) in Hypertensive Subjects

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol

20 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Nifedipine: individual responses and concentration-effect relationships

20 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Ketanserin concentration-effect relationships in individual hypertensive patients

20 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Concentration-effect relationships and individual responses to doxazosin in essential hypertension

20 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Kinetic-dynamic relations and individual responses to enalapril

20 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

The description and prediction of antihypertensive drug response: an individualised approach

20 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol

20 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Predictability of antihypertensive responsiveness and alpha-adrenoceptor antagonism during prazosin treatment

20 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Factors influencing the hypotensive effects of calcium antagonists

20 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

20 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Relation between initial blood pressure and its fall with treatment.

20 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

20 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

20 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Mortality in patients of the Glasgow Blood Pressure Clinic

20 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Concentration effect modelling with converting enzyme inhibitors in man.

20 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Nifedipine. Relationship between pharmacokinetics and pharmacodynamics

20 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Prazosin plasma concentration and blood pressure reduction

20 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding

20 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker.

20 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

20 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

The effects of age on the pharmacokinetics, antihypertensive efficacy and general tolerability of dilevalol

20 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide

20 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Individualization of antihypertensive therapy

20 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metabolite

20 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Prediction of the antihypertensive response to enalapril

20 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Plasma nifedipine levels and fall in blood pressure in a 53 year old woman

20 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Labetalol disposition and concentration-effect relationships during pregnancy

20 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

20 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Initial blood pressure as a predictor of the response to antihypertensive therapy

20 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

20 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man

20 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Rapid development of tolerance to the antihypertensive effect of nisoldipine

20 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

The modelling of drug response

20 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Quantitative analysis of the disopyramide concentration-effect relationship

20 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Modelling theophylline response in individual patients with chronic bronchitis

20 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

Relation of propranolol plasma level to beta-blockade during oral therapy

20 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0163-7258(92)90044-Z

20 October 2022

Identifiers

1 reference

13 August 2017

1 reference